Assistant Professor, Medicine, Perelman School of Medicine
Hematology
Dr. Alison W. Loren, MD
|
|
Give Review
Alison W. Loren, MD works in the field of Hematology. She attended Washington University School of Medicine in St. Louis. She received awards:"CMS Meaningful Use Stage 1 Certification". Alison Loren is a published doctor. She published 55 publications, including: 'Infusion of CD3/CD28 co-stimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment.' She is registered with Medicare.
Publications
- Infusion of CD3/CD28 co-stimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance enGraftment.
- Increasing incidence of Chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.
- DNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia.
- Comparison of Outcomes of Allogeneic Transplantation for CML with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan or TBI.
- Acute cholecystitis is a common complication following allogeneic SCT and is associated with use of total parenteral nutrition.
- Long-term Survival and Late Effects among 1-year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Synd...
- R-CHOP or R-HyperCVAD With or Without Autologous Stem Cell Transplantation for Older Patients With Mantle Cell Lymphoma.
- Early donor chimerism levels predict relapse and survival after allogeneic stem-cell transplantation with reduced intensity conditioning.
- Second solid Cancers after allogeneic hematopoietic cell transplantation using reduced intensity conditioning.
- Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: A report of 5 cases from the Southern Network on Adverse Reactions (SONAR) proj...
- Contraceptive use and the role of contraceptive counseling in reproductive-aged women with Cancer.
- Clinical guide to fertility preservation in hematopoietic cell transplant recipients.
- Development of Lymphomas Containing Epstein-Barr Virus After Therapy With Hyper-CVAD Regimen.
- CLL/SLL diagnosed in an adolescent.
- Providing Personalized Prognostic Information for Adult Leukemia Survivors.
- Better Leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared to TBI.
- Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhi...
- Receipt of maintenance therapy is most predictive of survival in older Acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens.
- Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in Acute myeloid leukemia.
- Fertility Preservation for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
- Interleukin-31 Is Produced by the Malignant T-Cell Population in Cutaneous T-Cell Lymphoma and Correlates with CTCL Pruritus.
- A Pilot Study of Prophylactic Ex Vivo Co-Stimulated Donor Leukocyte Infusions After Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation.
- Physician perceptions and practice patterns regarding fertility preservation in hematopoietic cell transplant recipients.
- Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.
- Potential prolongation of PFS in mantle cell Lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance.
- Blockade of lymphocyte chemotaxis in visceral Graft-versus-host disease.
- Allogeneic hematopoietic SCT for primary cutaneous T cell Lymphomas.
- Congestive heart failure in a patient with cutaneous T-cell Lymphoma treated with low-dose interferon alfa-2b.
- Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Resear...
- A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory Acute myelogenous leukemia.
- Utility of the systemic inflammatory response Syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignancies.
- A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 Acute myeloid leukemia.
- Lethal vascular leak Syndrome after denileukin diftitox administration to a patient with cutaneous gamma/delta T-cell lymphoma and occult cirrhosis.
- Post-transplant outcomes of induction therapy for Myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphala...
- Ultraviolet recall reaction after total body irradiation, etoposide, and methotrexate therapy.
- Evidence of myeloid differentiation in non-M3 Acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene.
- Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation.
- Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation.
- Post-transplant lymphoproliferative disorder.
- Efficacy of HPA-1a (PlA1)-negative platelets in a patient with post-transfusion purpura.
- Retransplantation of a cardiac alloGraft inadvertently harvested from a donor with metastatic melanoma.
- Derivation of malignancy status from ICD-9 codes.
- Re: Life after radical proStatectomy: a longitudinal study.
- A predictive model for the detection of tumor lysis Syndrome during AML induction therapy.
- A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation.
- Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory Acute GVHD.
- Donor characteristics affecting Graft failure, Graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for he...
- Differentiation syndrome in non-M3 Acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene.
- Trisomy 8 in an allogeneic stem cell transplant recipient representative of a donor-derived constitutional abnormality.
- Prognostic value of FDG-PET scan imaging in Lymphoma patients undergoing autologous stem cell transplantation.
- Donor leukocyte infusions for the treatment of relapsed Acute leukemia after allogeneic stem cell transplantation.
- Post-transplant lymphoproliferative disorder: a review.
- Intensive Graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation.
- Severe eosinophilia as a manifestation of Acute graft-versus-host disease.
Schools
Washington University St Louis
Hospital University Pa
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Burkitt's Lymphoma
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Pennsylvania Health System -
Washington University School of Medicine in St. Louis
Hospital
-
Hospital of the University of Pennsylvania -
Penn Presbyterian Medical Center
Drug Facts
| NPI NUMBER | 1942241641 | |
| NPPES Provider LastName | LOREN | |
| NPPES Provider FirstName | ALISON | |
| NPPES Provider ZIPCode | 19104 | |
| NPPES Provider State | PA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 446.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 2.91 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1942241641 |
| Last Name Of The Provider | LOREN |
| First Name Of The Provider | ALISON |
| View All |
Similar Doctors
|
|
Dr. Ryan M. Weight, DO |
|
|
Dr. Janghee Woo, MD |
|
|
Dr. Henry Fung, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Sheikh A. Ali, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frederick G. Dold, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Akhil Chopra, MD |
|
|
Dr. Tingting Tan, MD |
|
|
Dr. Anu A. Venkat, MD |
|
|
Dr. Debora R. Sekiguchi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen A. Liebhaber, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. William Biermann, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Allison M. Zibelli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leslie A. Fecher, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Andrew E. Chapman, DO |
|
Dr. Lewis J. Rose, MD
This Doctor is OpenDoctor Recommended.
|